Aim-To obtain insight into the effects of oestrogen on extracellular matrix (ECM) in the postmenopausal endometrium. Methods-The distribution of the components of the ECM, including collagen types I, III, IV, and VI, and laminin, was investigated in the human postmenopausal endometrium by an indirect immunofluorescence method with specific monoclonal antibodies and a polyclonal antibody. Collagens were also extracted from the endometrial tissues of postmenopausal women who had or had not been treated with oestrogen for three weeks.
investigated in the human postmenopausal endometrium by an indirect immunofluorescence method with specific monoclonal antibodies and a polyclonal antibody. Collagens were also extracted from the endometrial tissues of postmenopausal women who had or had not been treated with oestrogen for three weeks.
Results-Immunohistochemical studies demonstrated that type I collagen was the predominant interstitial collagen, and that types III and VI collagens were absent or very sparsely distributed in the stroma of the postmenopausal endometrium. However, types I, III, and VI collagens were diffusely localised in the stroma of the postmenopausal endometrium after administration of oestrogen. Even though type IV collagen was not seen in the basement membrane of the endometrial glands in the endometrium of postmenopausal women in the absence of oestrogen treatment, both type IV collagen and laminin were localised exclusively in the basement membrane of the endometrial glands in the postmenopausal endometrium after three weeks of oestrogen treatment. The level of type III collagen relative to that of type I collagen was significantly increased (p < 0.01) in the endometrium of oestrogen treated postmenopausal women compared with nontreated postmenopausal women. Conclusions-Conjugated equine oestrogen might induce changes in the distribution of components and in the composition of the ECM in the endometrium of postmenopausal women. reactions were recognised among these antibodies. A polyclonal antibody specific for human laminin (Gibco Lab Co, Grand Island, New York, USA) was used that did not cross react with types I, III, IV, or VI collagens or fibronectin.
IMMUNOHISTOCHEMISTRY
Immunohistochemical analysis was performed by the standard indirect immunofluorescence method. In brief, 3 gm frozen sections were rehydrated in phosphate buffered saline (PBS) at room temperature. They were incubated with the primary antibody (diluted 1/100 in PBS) for 12 hours at 4°C in a humidified chamber. After incubation, each section was incubated for one hour at room temperature with human plasma preabsorbed, fluorescein isothiocyanate conjugated goat antibodies against mouse or rabbit immunoglobulins that had been diluted 1/100 in PBS (Organon Teknik, Co, West Chester, Pennsylvania, USA).
SDS-PAGE OF PEPSIN SOLUBILISED COLLAGENS
Minced samples of human endometrium were washed overnight in cold distilled water and freed from blood. Tissues were homogenised in 50 volumes of 0.5 M acetic acid that contained 1 mg/ml pepsin (Sigma, St Louis, Missouri, USA). Collagens were extracted by previously described methods.7 The solubility of the tissue collagen from each endometrial sample was estimated by comparing the hydroxyproline content of the initial homogenate with that of the final solution of collagen.8 Estimation of the relative abundance of the al(III) chain was performed by interrupted gel electrophoresis.7 Electrophoresis was performed in an 8% polyacrylamide slab gel (Sigma) as previously described.9 Aliquots of 25 ml of each solution of heat denatured collagens were applied to the gel and subjected to electrophoresis at 80 mA. After 1.5 hours the current was switched off and sample wells were filled with a solution of 20% P mercaptoethanol (Wako Chemical Co, Osaka, Japan) in gel buffer for one hour to cleave the intramolecular disulphide bonds of type III collagen, (al (III))3. Then electrophoresis was resumed and allowed to continue for another hour. Each collagen a chain was stained with Coomassie brilliant blue (Sigma) and measured by densitometry. The relative amounts of al(III) chains were calculated by dividing the intensities of bands of al(III) by those of al (I).
STATISTICAL ANALYSIS
The ratios of intensity of bands of al(III) to al(I) chains, as estimated by densitometry, were represented as means (SEM), and analysed by analysis of variance (ANOVA) and Student's t test, using a StatView software program on a Macintosh computer. Two tailed p values of less than 0.05 were considered significant. D-F) .
Components of the basement membrane
In the endometrium of non-treated women, no immunostaining with the MoAb against type IV collagen was observed on the basement membrane of endometrial glands (fig 2A) . However, immunostaining with the polyclonal antibody against laminin was observed on the basement membrane of the endometrial glands ( fig 2B) . In contrast, strong immunofluorescence specific for type IV collagen and laminin was detected on the basement membrane of endometrial glands (figs 2C and D) in the endometrium of oestrogen treated women.
The intensity of immunostaining of the endometrial tissues from non-treated and oestrogen treated postmenopausal women by each of the antibodies against components of the ECM was subjectively graded from 1 + to 3+ and the results are summarised in table 1.
INTERRUPTED SDS-PAGE OF PEPSIN SOLUBILISED COLLAGENS FROM THE ENDOMETRIUM
Interrupted SDS-PAGE revealed that the relative level of acl (III) chains was higher and that of a 1 (I) chain was lower in the endometrium of postmenopausal women treated with oestrogen than they were in the endometrium of non-treated postmenopausal women (fig 3) . The ratio of the intensity of the band of al (III) to that of al(I) was (mean (SEM)) 0.07 (0.01) and 0.34 (0.10) for the endometrium of non-treated women and the endometrium of oestrogen treated women, respectively. The ratio of the intensity of the band of al (III) to that of a 1(I) from the endometrium of oestrogen treated women was significantly higher than that from the endometrium ofnon-treated women (p < 0.01) (fig 4) .
Discussion
We investigated changes in the distribution of components and the composition of the ECM, including collagen types I, III, IV, and VI, and laminin, in the human postmenopausal endometrium with and without three weeks of oestrogen treatment. We were able to solubilise 70-85% of the collagen in the human endometrial tissues, as determined by reference to levels of hydroxyproline (data not shown). Therefore, we postulated that the extracted collagen might accurately reflect the entire complement of collagen in the tissues.
In the postmenopausal endometrium of women without oestrogen treatment, our immunohistochemical observations confirmed that type I collagen was the predominant inter: stitial collagen and that laminin was present on the basement membrane of endometrial glands. The endometrium of postmenopausal women treated with conjugated equine oestro- 
